Xeptiva Therapeutics

United States
Lander, Wyoming, United States

Company profile

Xeptiva Therapeutics company profile

Xeptiva Therapeutics is a veterinary biotechnology company that focuses on developing therapies for chronic inflammation conditions in companion animals. Its main products target chronic pain associated with osteoarthritis and atopic dermatitis in dogs. In addition, the company is developing therapies for the treatment of pain in horses and asthma in cats. Xeptiva's goal is to allow pets to live longer and healthier by targeting the underlying source of many chronic diseases.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$3M
Last funding
Seed / $2.5M / 2024-09-23
Last equity funding
Seed / $2.5M
Investors
6
Lead investors
1
Founders
3
Articles
9

Founders and investors

Founders

Emiliano TriasJosefina CorreaLuis Barbeito

Lead investors

Zentynel Frontier Investments

Investors

Fen VenturesiThink VCNDLATAMSergio FogelZentynel Frontier Investments